Recent News

• 09.08.2025 - HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Complete the Acquisition of Dura Medical; Initial Acquisition in Network of Interventional Psychiatry Clinics
• 09.08.2025 - HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Complete the Acquisition of Dura Medical; Initial Acquisition in Network of Interventional Psychiatry Clinics
• 09.08.2025 - September 8, 2025 - September 8, 2025 : H.C. Wainwright 27th Annual Global Investment Conference
• 09.08.2025 - September 8, 2025 - September 8, 2025 : H.C. Wainwright 27th Annual Global Investment Conference
• 09.03.2025 - NRx Pharmaceuticals (NASDAQ:NRXP) to Participate in a Fireside Chat at H.C. Wainwright's 27th Annual Global Investment Conference on Monday, September 8th
• 09.03.2025 - NRx Pharmaceuticals (NASDAQ:NRXP) to Participate in a Fireside Chat at H.C. Wainwright's 27th Annual Global Investment Conference on Monday, September 8th
• 08.27.2025 - NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Expanded Access Policy for NRX-100 (preservative-free ketamine)
• 08.27.2025 - NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Expanded Access Policy for NRX-100 (preservative-free ketamine)
• 08.18.2025 - NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Second Quarter 2025 Financial Results and Provides Corporate Update
• 08.18.2025 - NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Recent Filings

• 09.08.2025 - EX-99.1 EX-99.1
• 09.08.2025 - 8-K Current report
• 08.21.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 08.21.2025 - 3 Initial statement of beneficial ownership of securities
• 08.18.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.18.2025 - 8-K Current report
• 08.18.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 08.18.2025 - EX-99.1 EX-99.1